.Pharmacolibrary.Drugs.C_CardiovascularSystem.C03A_LowCeilingDiureticsThiazides.C03AB05_PolythiazideAndPotassium.PolythiazideAndPotassium .Pharmacolibrary.Drugs.C_CardiovascularSystem.C03A_LowCeilingDiureticsThiazides.C03AB05_PolythiazideAndPotassium.PolythiazideAndPotassium| name: | PolythiazideAndPotassium | |
| ATC code: | C03AB05 | route: | oral |
| compartments: | 1 | |
| dosage: | 2 | mg |
| volume of distribution: | 3 | L |
| clearance: | 0.1 | L/h/kg |
| other parameters in model implementation | ||
Polythiazide is a long-acting thiazide diuretic used primarily in the management of hypertension and edema. It is often co-formulated with potassium to counteract thiazide-induced hypokalemia. This combination was approved and marketed in some regions historically for hypertension, but its use today is limited, and it is not widely available.
Estimated pharmacokinetic parameters for polythiazide in adult healthy individuals. No direct studies using the combination with potassium were identified; parameter estimates are based on polythiazide monotherapy literature.